NITRIC OXIDE EFFECTS ON PULMONARY ENDOTHELIAL CELLS
一氧化氮对肺内皮细胞的影响
基本信息
- 批准号:2392762
- 负责人:
- 金额:$ 18.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 1998-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pulmonary vascular endothelial cells are exposed to nitric oxide (NO) from
both exogenous environmental sources and from endogenous cellular sources.
Numerous cellular responses to NO are possible ranging from signalling
events related to elevation of cGMP to cytostatis and cytotoxicity. These
responses depend on both the concentration of NO and the length of
exposure. In general, transient activation of NO synthase (NOS) leads to
signalling responses while prolonged NO production following induction of
NOS (inflammation) or prolonged exposure to NO in the environment is
associated with dramatic alterations in cellular function and potentially
cell death. NO is a redox active molecule which under aerobic conditions
can react with and modify protein sulfhydryls, enzyme iron/sulfur
complexes, protein heme iron, and other reactive groups. Recent evidence
in the literature and our own preliminary data suggests that NO modifies
protein sulfhydryls, particularly those with low pK/a's which are
associated with the active site of many proteins including dehydrogenases.
In this project, we will determine the mechanisms through which NO
modifies active site sulfhydryls in dehydrogenases with glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as the prototypical enzyme. GAPDH is
particularly important in this regard because this enzyme is key for cell
viability in lung endothelial cells since these cells are dependent almost
exclusively on glycolysis for ATP generation. In other cells types,
oxidative inhibition of GAPDH by mediators other than NO is associated
with cell death and involves oxidation of the active site sulfhydryl.
Recent work by others using isolated enzyme preparations has established
GAPDH as a potential target for NO modification presumably at the same
sulfhydryl. However the exact nature of the modification or whether
modifications can occur in intact cells is not known. Moreover, the role
of cellular antioxidant systems such as the glutathione redox cycle,
glutaredoxin, and thioredoxin, in regulating the extent of NO-induce
injury is not known. Our hypothesis is that NO inhibits GAPDH activity in
intact cells via mechanisms similar to those that occur in isolated enzyme
preparations and that the extent of inhibition is regulated by the redox
status of the cell. Our approach will be to determine mechanisms by which
NO inhibits GAPDH, investigate the reversibility of inhibition and
investigate the role of cellular redox mechanisms in regulating these
events. Experiments will be carried out using isolated enzyme systems and
intact pulmonary artery endothelial cells.
肺血管内皮细胞暴露于一氧化氮(NO)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A RICHARD WHORTON其他文献
A RICHARD WHORTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A RICHARD WHORTON', 18)}}的其他基金
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7748012 - 财政年份:2009
- 资助金额:
$ 18.78万 - 项目类别:
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
8235748 - 财政年份:2009
- 资助金额:
$ 18.78万 - 项目类别:
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7997191 - 财政年份:2009
- 资助金额:
$ 18.78万 - 项目类别:
Regulation of Rho Signaling by S-Nitrosothiols
S-亚硝基硫醇对 Rho 信号传导的调节
- 批准号:
7580056 - 财政年份:2009
- 资助金额:
$ 18.78万 - 项目类别:
CELLULAR REDOX CONTROL AND NITRIC OXIDE SIGNALING
细胞氧化还原控制和一氧化氮信号传导
- 批准号:
2907116 - 财政年份:1999
- 资助金额:
$ 18.78万 - 项目类别:
CELLULAR REDOX CONTROL AND NITRIC OXIDE SIGNALING
细胞氧化还原控制和一氧化氮信号传导
- 批准号:
6184716 - 财政年份:1999
- 资助金额:
$ 18.78万 - 项目类别:
相似海外基金
Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
- 批准号:
23H01824 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
- 批准号:
23K06723 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
- 批准号:
23K14019 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
- 批准号:
10752901 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
- 批准号:
10760626 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Development of Coccidioides Cytokine Release Assay
球孢子菌细胞因子释放测定的发展
- 批准号:
10760131 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Generating a novel conditional knockout mouse for a super-enhancer that controls cytokine responsiveness
生成一种新型条件敲除小鼠,用于控制细胞因子反应的超级增强子
- 批准号:
10740932 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Cytokine receptor common beta chain alterations in mediastinal lymphomas
纵隔淋巴瘤细胞因子受体常见β链改变
- 批准号:
489197 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Operating Grants